BiotechTube
Carlsbad Technology

Carlsbad Technology

Carlsbad, United States· Est.
carlsbadtech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Carlsbad Technology, founded in 2003 (with roots dating to 1990), is a private, commercial-stage company headquartered in Carlsbad, California. It serves as a critical link in the global generic pharmaceutical and health product supply chain, combining manufacturing, distribution, sales, marketing, and regulatory consulting. Its core strength lies in its integration with the YungShin Group, providing access to Asian manufacturing innovation and expertise for the American markets. The company is revenue-generating with an established portfolio of generic drugs and consumer health products like ProOcular contact lenses.

Generic Drugs

Technology Platform

Integrated supply chain and regulatory platform for generic drugs and health products, built on cGMP manufacturing, quality systems, and FDA advisory services, leveraging the YungShin Group's infrastructure.

Opportunities

The company is well-positioned to capitalize on the growing demand for affordable generic drugs and the trend of cross-Pacific health product trade.
Its unique 'bridge' model allows it to commercialize proven Asian health innovations in the large U.S.
market, as demonstrated by its contact lens launch.

Risk Factors

Key risks include severe regulatory and compliance exposure to the FDA, potential supply chain disruptions across the Pacific, and intense price competition in the core generic pharmaceuticals market.
Its reliance on the YungShin Group also presents a concentration risk.

Competitive Landscape

Carlsbad Tech competes with large generic drug manufacturers (e.g., Teva, Mylan), niche contract manufacturing organizations (CMOs), and distribution companies. Its differentiation lies in its combined offering of manufacturing, regulatory advisory, and Asia-U.S. market bridging, a niche not fully served by larger, more siloed competitors.

More companies in Small Molecule Drugs →More companies in United States →